期刊文献+

血脂异常及糖尿病心血管合并症的治疗分析 被引量:1

下载PDF
导出
摘要 目的分析血脂异常及糖尿病心血管合并症的治疗分析及治疗效果。方法随机选取在2016年12月—2017年12月期间该院收治的血脂异常及糖尿病心血管合并症患者82例,按照数字随机表法分为两组,每组患者41例。两组患者经合理饮食、运动、戒烟忌酒等常规治疗基础上,对照组患者经磷酸西格列汀治疗,观察组患者经阿托伐他汀钙片联合磷酸西格列汀治疗,对比两组患者治疗效果。结果观察组治疗后TC、TG、LDL-C低于对照组,HDL-C高于对照组,心血管事件发生率4.88%低于对照组24.39%;差异有统计学意义(P<0.05)。结论对血脂异常及糖尿病心血管合并症患者在常规治疗基础上,联合阿托伐他汀钙片与磷酸西格列汀治疗,可有效控制患者血糖及血脂变化,减少心血管合并症的发生,效果显著。
作者 姜国攀
出处 《糖尿病新世界》 2018年第21期29-30,共2页 Diabetes New World Magazine
  • 相关文献

二级参考文献75

  • 1王椿,喻红玲,梁荩忠,田浩明.糖尿病教育对2型糖尿病患者血糖控制的影响[J].中国循证医学杂志,2004,4(7):508-511. 被引量:17
  • 2Dunn FL. Management of dyslipidemia in people with type 2 diabetes mellitus[J].Reviews in Endocrine and Metabolic Disorders,2010,(01):41-51.
  • 3Haffner SM,Lehto S,R(o)nnemaa T. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction[J].New England Journal of Medicine,1998,(04):229-234.
  • 4Cholesterol Treatment Trialists' (CTT) Collaboration,Baigent C,Blackwell L. Efficacy and safety of more intensive lowering of LDL cholesterol:a meta-analysis of data from 170,000 participants in 26 randomised trials[J].Lancet,2010,(9753):1670-1681.
  • 5Graham I,Atar D,Borch-Johnsen K. European guidelines on cardiovascular disease prevention in clinical practice:executive summary:Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)[J].European Heart Journal,2007,(19):2375-2414.doi:10.1093/eurheartj/ehm316.
  • 6Baigent C,Keech A,Kearney PM. Efficacy and safety of cholesterol-lowering treatment:prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins[J].Lancet,2005,(9493):1267-1278.doi:10.1016/S0140-6736(05)67394-1.
  • 7Cannon CP,Steinberg BA,Murphy SA. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy[J].Journal of the American College of Cardiology,2006,(03):438-445.doi:10.1016/j.jacc.2006.04.070.
  • 8Knopp RH,d'Emden M,Smilde JG. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes:the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)[J].Diabetes Care,2006,(07):1478-1485.doi:10.2337/dc05-2415.
  • 9Wanner C,Krane V,M(a)rz W. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis[J].New England Journal of Medicine,2005,(03):238-248.
  • 10Amarenco P,Bogousslavsky J,Callahan A 3rd. High-dose atorvastatin after stroke or transient ischemic attack[J].New England Journal of Medicine,2006,(06):549-559.

共引文献65

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部